agendia mammaprint microarray (Agendia BV)
90
Structured Review
Agendia BV
agendia mammaprint microarray
Agendia Mammaprint Microarray, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene-expression+test/agendia+microarray/pmc03315840-59-19-18
Average 90 stars, based on 1 article reviews
Agendia Mammaprint Microarray, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene-expression+test/agendia+microarray/pmc03315840-59-19-18
Average 90 stars, based on 1 article reviews
agendia mammaprint microarray - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models"
Article Title: The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Journal: Nature Biotechnology
doi: 10.1038/nbt.1665
Figure Legend Snippet: Microarray data sets used for model development and validation in the MAQC-II project
Techniques Used: Microarray, Generated, Positive Control, Negative Control
Related Articles
Expressing:Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: .. SOD3 expression is downregulated in Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: .. Two breast cancer datasets in Oncomine, the Curtis Breast [ 20 ] ( )) and Gluck Breast [ 21 ] ( )) also show that the lowest SOD3 expression levels were detected in Luminal B breast cancers (red arrow). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1. caption a7 SOD3 expression is downregulated in breast cancer. (a) Comparison of SOD3 expression in breast tumours versus normal breast tissues with other:Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: The tissue type is indicated on the left edge of the heatmap Luminal B subtype shows the highest correlation of SOD3 methylation with its expression We then determined the correlation between the % methylation and Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas. Article Snippet: Luminal B subtype shows the highest correlation of SOD3 methylation with its expression We then determined the correlation between the % methylation and Polymerase Chain Reaction:Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. Treatment‐related adverse events ( n = 67) Analysis of Biomarkers with pCR : DRD Mutation, TNBC Molecular Subtype, TILs , and GSIS Of 67 patients, Mutagenesis:Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. Treatment‐related adverse events ( n = 67) Analysis of Biomarkers with pCR : DRD Mutation, TNBC Molecular Subtype, TILs , and GSIS Of 67 patients, Microarray:Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. Treatment‐related adverse events ( n = 67) Analysis of Biomarkers with pCR : DRD Mutation, TNBC Molecular Subtype, TILs , and GSIS Of 67 patients, Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas. Article Snippet: We thank Oleg Shats (Assistant Director for Cancer Informatics at UNMC), Dr. David Kelly (Director, Molecular Biology Core Facility, Eppley Cancer Institute, UNMC) for clinical data verification. .. We also acknowledge the contribution by Dr. Peng Xiao (Director, Bioinformatics and Systems Biology Core, UNMC) for analyzing the Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. All subsequent biomarker analysis is based on the 63 patients with Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. Of 67 patients, Comparison:Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: .. Two breast cancer datasets in Oncomine, the Curtis Breast [ 20 ] ( )) and Gluck Breast [ 21 ] ( )) also show that the lowest SOD3 expression levels were detected in Luminal B breast cancers (red arrow). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1. caption a7 SOD3 expression is downregulated in breast cancer. (a) Comparison of SOD3 expression in breast tumours versus normal breast tissues with Biomarker Discovery:Article Title: Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Article Snippet: .. All subsequent biomarker analysis is based on the 63 patients with |